DEMANT A/S

Oticon Medical is a manufacturer of bone-anchored hearing systems (BAHS) and bone conduction hearing solutions for children and adults with conductive, mixed, or single-sided sensorineural hearing loss. The company is part of the Demant Group and develops implantable and non-invasive hearing devices that bypass damaged portions of the ear to deliver sound directly to the inner ear via bone conduction. Primary product lines include the Ponto system (bone-conduction hearing processors available in multiple generations including Ponto 5 and Ponto 5 SuperPower), the Sentio transcutaneous system, and the Softband for pediatric candidates. Oticon Medical serves audiologists, hearing healthcare professionals, and patients globally through a network of local clinics and representatives. The company provides clinical support, online resources, batteries, and counseling tools through bahsjourney.com. Following the sale of their cochlear implant business in 2024, Oticon Medical remains focused exclusively on bone-anchored hearing aid development and patient support. Products are designed for implantation or transcutaneous use and marketed for use in educational, professional, and social settings. The company maintains regulatory compliance and operates through a global distribution network with localized support in multiple countries including the United States.